
Emerging safety signals and why clinicians are watching closely New research presented to medical audiences has signalled a possible, modest association between GLP‑1 receptor agonists — the class of drugs behind household names used for diabetes and weight l…
New research presented to medical audiences has signalled a possible, modest association between GLP1 receptor agonists the class of drugs behind household names used for diabetes and weight loss and… [+1752 chars]









